MYD88 and lymphoma: They hypothesized that the mutation could be linked to a more aggressive phenotype.[39] According to our findings, individuals with the MYD88 L265P mutation were characterized by being at an advanced stage, which raises the possibility that the mutation may be crucial in the development of lymphoma and be linked to a worse prognosis for the disease.